Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 84 Cisplatin 79 Pemetrexed 72 Docetaxel 62 Drug Therapy 44 Gemcitabine 43 Erlotinib Hydrochloride 42 Gefitinib 38 Radiotherapy 36 Paclitaxel 36 pembrolizumab 31 Bevacizumab 29 icotinib 28 osimertinib 27 anlotinib 26 Nivolumab 26 camrelizumab 23 Vinorelbine 23 Radiosurgery 20 aumolertinib 18 atezolizumab 17 sintilimab 16 apatinib 16 Endostatins 16 endostar protein 15 durvalumab 14 Surgical Procedures, Operative 13 Immunotherapy 13 Immune Checkpoint Inhibitors 12 Blood Specimen Collection 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Non-Small-Cell Lung × talactoferrin alfa × Clear all

NCT00706862 2012-03-15

FORTIS-C

Agennix

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡